Clinical Trial Update: Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating aprepitant to prevent cisplatin-induced delayed emesis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: S. Maria Hospital, Terni | Conditions: Emesis | Phase 3 | Status: TERMINATED